Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,765
Total Claims
$263K
Drug Cost
250
Beneficiaries
$1,053
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-25%
Cost per patient vs peers
$1,053 vs $1,411 avg
-44%
Brand preference vs peers
5.9% vs 10.6% avg
Brand vs Generic
Brand: 685 claims · $162K
Generic: 10,908 claims · $98K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Nph Hum/Reg Insulin Hm | 126 | $42K |
| Apixaban | 52 | $34K |
| Sitagliptin Phos/Metformin Hcl | 25 | $17K |
| Dapagliflozin Propanediol | 22 | $16K |
| Rivaroxaban | 25 | $14K |
| Insulin Nph Human Isophane | 40 | $12K |
| Atorvastatin Calcium | 1,233 | $9,019 |
| Losartan Potassium | 388 | $4,631 |
| Metoprolol Succinate | 433 | $4,090 |
| Levothyroxine Sodium | 68 | $4,015 |
| Lisinopril | 818 | $3,477 |
| Levothyroxine Sodium | 243 | $3,419 |
| Metformin Hcl | 791 | $3,158 |
| Amlodipine Besylate | 781 | $2,980 |
| Candesartan/Hydrochlorothiazid | 19 | $2,518 |
Prescribing Profile
Patient Profile
73
Avg Age
48%
Female
2.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data